- Staat
- MD
- Alter
- 11,0
- Geschlecht
- F
- Eingang
- 22.11.2021
- Impfdatum
- 22.11.2021
- Beginn
- 22.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
Crying
Dizziness
Dyskinesia
Fall
Head injury
Seizure
Symptomtext
patient receiving age appropriate shots. TdaP and Menveo given then Gardasil. Within 1 minute of last injection, she began to feel faint and fell forward and was caught by the M A but hit her head on the tile. She then began to seize with arms jerking for a few seconds (less than 20) she was placed on the ground and on her side. She then came to and started to cry and answered questions appropriately. Her pulse was 86. Her pulse ox was 100 percent. Her BP was 100/65. EMS was called. She was taken to ED for further evaluation.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Seizure
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- NONE
- Vorgeschichte
- NONE, MILD SEASONAL ALLERGIES
- Andere Medikamente
- ZYRTEC AND MULTIVITAMIN
- Allergien
- NONE
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 31,0
- Geschlecht
- M
- Eingang
- 08.11.2021
- Impfdatum
- 08.11.2021
- Beginn
- 08.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
Hypotension
Loss of consciousness
Syncope
Symptomtext
SYNCOPE WITHIN 10 MINUTES. PATIENT REGAINED CONSCIOUSNESS ALMOST IMMEDIATELY. EMS RESPONDED AND BLOOD PRESSURE REMAINED VERY LOW FOR ANOTHER 15 MINUTES. SUBJECT WAS REFERRED TO AN URGENT CARE CLINIC
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Loss of consciousness
- Hospital-Tage
- -
- Labordaten
- BLOOD PRESSURE
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 35,0
- Geschlecht
- F
- Eingang
- 19.10.2021
- Impfdatum
- 29.09.2021
- Beginn
- 16.10.2021
- Tage bis Beginn
- 17,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Bell's palsy
Symptomtext
Pt became symptomatic with Bell's Palsy two weeks after receiving her flu vaccine. Pt will be treated with steroids over several weeks and comfort measures to be provided to assist with symptoms.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Bell's palsy
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- prenatal vitamins baby aspirin
- Allergien
- no known allergies
- Vorherige Impfungen
- -
- Staat
- UT
- Alter
- 27,0
- Geschlecht
- F
- Eingang
- 23.02.2022
- Impfdatum
- 18.01.2022
- Beginn
- 19.01.2022
- Tage bis Beginn
- 1,0
- Dosis
- UNK
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Hypoaesthesia
Paraesthesia
Symptomtext
On 1/25/22, Patient contacted Nurse to report numbness and tingling to her L arm and right leg that started the day after receiving the listed 5 vaccinations. Nurse referred her to clinic. On 1/31/22 she had her first clinic visit where she was instructed to use ice 2-3 times per day, 15 min. at a time, home stretches, and follow up in 2 weeks. Regular duty. Second clinic visit on 2/7/22 added prednisone to the treatment regime with follow up in 10 days. Third clinic visit on 2/15/22 added Gabipentin and Physical Therapy
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Paraesthesia
- Hospital-Tage
- -
- Labordaten
- None known
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Lyme Disease (10 Years ago),
- Andere Medikamente
- Spironolactone, Kylena IUD, Vitamin C
- Allergien
- Egg intolerance (Nausea/vomiting after consumption).
- Vorherige Impfungen
- -
- Staat
- MA
- Alter
- 21,0
- Geschlecht
- M
- Eingang
- 02.03.2023
- Impfdatum
- 29.06.2021
- Beginn
- 29.06.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- - / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Chills
Myalgia
Nausea
Pyrexia
Symptomtext
chills, nausea, muscle aches, fever overnight. Treated with rest and tylenol
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chills
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- none
- Allergien
- penicillins
- Vorherige Impfungen
- fever, 21, 02/10/2021, COVID 2nd dose, Pfizer
- Staat
- -
- Alter
- 37,0
- Geschlecht
- F
- Eingang
- 11.04.2022
- Impfdatum
- 05.04.2022
- Beginn
- 05.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Chills
Fatigue
Headache
Pain
Symptomtext
Employee reports that later the same day she began to have chillls, exhaustion, body aches and HA. No fever.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chills
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 55,0
- Geschlecht
- F
- Eingang
- 01.02.2022
- Impfdatum
- 10.01.2022
- Beginn
- 10.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Chills
Headache
Myalgia
Pyrexia
SARS-CoV-2 test negative
Symptomtext
Patient received TDAP (Boostrix) vaccine on 01/10/2022 and reported feeling muscle aches, severe chills, low grade fever, and headaches after vaccine. No visit to clinic or urgent care. Patient proceeded to take COVID test on 01/12/2022 and received negative results 01/14/2022. Patient reports to be asymptomatic on 01/14/2022. Per Tdap vaccine information sheet given to patient the day of vaccination on 01/10/2022 it was advised reaction was possible even though it was uncommon. Per patient's PCP no need for further testing or medications.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chills
- Hospital-Tage
- -
- Labordaten
- COVID-19 negative test result
- Aktuelle Erkrankungen
- n/a
- Vorgeschichte
- n/a
- Andere Medikamente
- n/a
- Allergien
- n/a
- Vorherige Impfungen
- -
- Staat
- HI
- Alter
- 28,0
- Geschlecht
- F
- Eingang
- 14.12.2021
- Impfdatum
- 13.12.2021
- Beginn
- 13.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Depressed level of consciousness
Dizziness
Injection site pruritus
Symptomtext
patient reported "itching" feeling at varivax injection site then "light-headedness", then slumped back and was less alert although some response always able to be elicited throughout. lasted 5 to 18 minutes.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dizziness
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 11,0
- Geschlecht
- F
- Eingang
- 07.09.2021
- Impfdatum
- 02.09.2021
- Beginn
- 03.09.2021
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Fatigue
Headache
Injection site erythema
Injection site pain
Injection site swelling
Malaise
Wrong product administered
Symptomtext
Patient was here for her 11 yr check, she was due for her Tdap, Hpv9 and MCV4, the patient was given Men-B. This was found upon doing the transfer report. I notified our Nurse Manager as well as the provider who Pt saw on 09/02, NP. NP contacted mom around 2:17pm on 09/03 to let her know she was given the wrong vaccine. Mom reported soreness of the injection site. Around 4pm on 09/03 the Health Department contacted our office to let us know mom called to report Pt wasn't feeling well, no specific symptoms were reported. I spoke with mother today, she states Pt was feeling a little more tired than normal, had a headache, and redness and swelling at the injection site. Pt is feeling better now.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Fatigue
- Hospital-Tage
- -
- Labordaten
- None.
- Aktuelle Erkrankungen
- None.
- Vorgeschichte
- None.
- Andere Medikamente
- None.
- Allergien
- None.
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 60,0
- Geschlecht
- F
- Eingang
- 03.04.2023
- Impfdatum
- 03.01.2022
- Beginn
- 05.01.2022
- Tage bis Beginn
- 2,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Cervical radiculopathy
Immunisation reaction
Symptomtext
Adverse effect of other vaccines and biological substances, initial encounter on 2022-01-05, Radiculopathy, cervical region on 2022-01-09.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cervical radiculopathy
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Type 2 diabetes mellitus without complications; Nontoxic multinodular goiter; Family history of ischemic heart disease and other diseases of the circulatory system; Presence of coronary angioplasty implant and graft; Type 2 diabetes mellitus without complications; Type 2 diabetes mellitus with hyperglycemia; Presence of coronary angioplasty implant and graft; Type 2 diabetes mellitus with hyperglycemia; Type 2 diabetes mellitus without complications; Dysuria; Encounter for screening for other viral diseases; Encounter for screening for malignant neoplasm of colon; Body mass index [BMI] 33.0-33.9, adult; Postmenopausal status NOS; Personal history of malignant melanoma of skin; Presence of coronary angioplasty implant and graft; Type 2 diabetes mellitus with hyperglycemia; Presence of coronary angioplasty implant and graft
- Vorgeschichte
- -
- Andere Medikamente
- SULFAMETHOXAZOLE-TRIMETHOPRIM 800-160 MG ORAL TABS
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NC
- Alter
- -
- Geschlecht
- F
- Eingang
- 27.08.2022
- Impfdatum
- 07.07.2022
- Beginn
- 07.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
administered on 07Jul2022, expiration date of 05Jul2022; This case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a female patient who received DTPa (Reduced antigen) (Boostrix) (batch number 229AN, expiry date 5th July 2022) for prophylaxis. Co-suspect products included dtpa vaccine. pre-filled syringe device (Boostrix Pre-Filled Syringe Device) injection syringe for prophylaxis. On 7th July 2022, the patient received Boostrix and Boostrix Pre-Filled Syringe Device. On 7th July 2022, unknown after receiving Boostrix and Boostrix Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt date: 18-Aug-2022 Reporter's Comments: A nurse reported a patient was administered Boostrix vaccine on 7th July 2022, which had an expiration date of 5th July 2022. At the time of reporting, the dose had not been repeated. Reporter declined to provide patient information aside from gender. The Vaccine Administration Facility is the same as Primary Reporter. The reporter consented to follow up. Additional Supportive Information: The patient received a dose of Boostrix, which was already expired, which led to expired vaccine used.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 16,0
- Geschlecht
- F
- Eingang
- 24.08.2022
- Impfdatum
- 09.08.2022
- Beginn
- 09.08.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
Patient received an expired dose; This case was reported by a pharmacist via call center representative and described the occurrence of expired vaccine used in a 16-year-old female patient who received DTPa (Reduced antigen) (Boostrix) (batch number 229AN, expiry date 5th July 2022) for prophylaxis. On 9th August 2022, the patient received Boostrix. On 9th August 2022, unknown after receiving Boostrix, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown. Additional Information: GSK Receipt Date: 16-AUG-2022 Reporter's Comments: The pharmacist reported that a patient received an expired dose of Boostrix on 9th Aug2022. The Boostrix expired on 5th Jul2022. The reporter gave consent to follow up. Additional Supportive Information: The patient received expired Boostrix vaccine, which lead to expire vaccine used. This case is linked to the case US2022119632, reported by the same reporter; Sender's Comments: US-GSK-US2022119632:Same reporter. Patient 1.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 50,0
- Geschlecht
- M
- Eingang
- 19.08.2022
- Impfdatum
- 09.08.2022
- Beginn
- 09.08.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
Patient received an expired dose; This case was reported by a pharmacist via call center representative and described the occurrence of expired vaccine used in a 50-year-old male patient who received DTPa (Reduced antigen) (Boostrix) (batch number 229AN, expiry date 5th July 2022) for prophylaxis. On 9th August 2022, the patient received Boostrix. On 9th August 2022, unknown after receiving Boostrix, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown. Additional Information: GSK Receipt Date: 16-AUG-2022 Reporter's Comments: The pharmacist reported that a male patient received an dose of Boostrix which was expired on 5th July 2022. The reporter consent to follow up. Additional Supportive Information: The patient received an expired dose of Boostrix, which led to expired vaccine used. This case has been linked with case US2022119634 reported by same reporter.; Sender's Comments: US-GSK-US2022119634:Same reporter. Patient 2.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 50,0
- Geschlecht
- M
- Eingang
- 12.08.2022
- Impfdatum
- 06.08.2022
- Beginn
- 06.08.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
administered Boostrix that expired; This case was reported by a pharmacist via call center representative and described the occurrence of expired vaccine used in a 50-year-old male patient who received DTPa (Reduced antigen) (Boostrix) (batch number 229AN, expiry date 5th July 2022) for prophylaxis. Co-suspect products included dtpa vaccine. pre-filled syringe device (Boostrix Pre-Filled Syringe Device) injection syringe for prophylaxis. On 6th August 2022, the patient received Boostrix and Boostrix Pre-Filled Syringe Device. On 6th August 2022, unknown after receiving Boostrix and Boostrix Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 09-AUG-2022 Reporter's Comments: The patient received expired vaccine. No reactions reported. The reporter consented to follow up via postal. Additional Supportive Information: The patient received Boostrix which was already expired, which led to expired vaccine used.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TN
- Alter
- 40,0
- Geschlecht
- M
- Eingang
- 28.07.2022
- Impfdatum
- 12.07.2022
- Beginn
- 12.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- - / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
Expired dose administered; This case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 40-year-old male patient who received DTPa (Reduced antigen) (Boostrix) (batch number 229AN, expiry date 5th July 2022) for prophylaxis. On 12th July 2022, the patient received the 1st dose of Boostrix. On 12th July 2022, unknown after receiving Boostrix, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown. Additional Information: GSK receipt date: 19-Jul-2022 Reporter comment: Certified medical assistant reported that expired dose was administered to a male patient. The reporter consented to follow up. Additional Supportive Information: The patient was administered an expired dose of Boostrix, which led to expired vaccine used.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- AZ
- Alter
- 75,0
- Geschlecht
- M
- Eingang
- 23.07.2022
- Impfdatum
- 19.07.2022
- Beginn
- 19.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
Administered boostrix that expired; This case was reported by a pharmacist via call center representative and described the occurrence of expired vaccine used in a 75-year-old male patient who received DTPa (Reduced antigen) (Boostrix) (batch number 229AN, expiry date 5th July 2022) for prophylaxis. On 19th July 2022, the patient received Boostrix. On 19th July 2022, unknown after receiving Boostrix, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown. Additional Information: GSK Receipt Date: 20-Jul-2022 Reporter's Comments: A medical assistant administered expired dose of Boostrix. The reporter did not consented to follow up. Additional Supportive Information: The patient was administered an expired dose of Boostrix, which led to expired vaccine used.; Sender's Comments: US-GSK-US2022108788:duplicate case
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- -
- Geschlecht
- U
- Eingang
- 23.07.2022
- Impfdatum
- 07.07.2022
- Beginn
- 07.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
boostrix expired administered; This case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a patient who received DTPa (Reduced antigen) (Boostrix) (batch number 229AN, expiry date 5th July 2022) for prophylaxis. On 7th July 2022, the patient received Boostrix. On 7th July 2022, unknown after receiving Boostrix, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown. Additional Information: GSK Receipt Date: 18-JUL-2022 Reporter's Comment: HCP (Health Care Professional) reported that an expired dose of Boostrix was administered to patient. The reporter consented to follow-up via phone. Additional Supportive Information: The patient received a dose of Boostrix vaccine which was already expired, which led to expired vaccine used.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 70,0
- Geschlecht
- F
- Eingang
- 16.07.2022
- Impfdatum
- 01.07.2022
- Beginn
- 01.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Accidental underdose
Needle issue
Symptomtext
underdose of Boostrix via needle leak on; administered underdose; This case was reported by a pharmacist via call center representative and described the occurrence of accidental underdose in a 70-year-old female patient who received DTPa (Reduced antigen) (Boostrix) (batch number 229AN, expiry date 5th July 2022) for prophylaxis. On 1st July 2022, the patient received Boostrix. On 1st July 2022, unknown after receiving Boostrix, the patient experienced accidental underdose. On an unknown date, the patient experienced needle leak. On an unknown date, the outcome of the accidental underdose and needle leak were unknown. Additional Information: GSK Receipt Date: 6-Jul-2022 Reporter's Comments: The pharmacist reported that the patient was administered an underdose of Boostrix The pharmacist stated administered an underdose of Boostrix via needle leak. Adverse event contained all reported information by health care professional. HCP gave consent for safety team follow up. Additional Supportive Information: The patient was administered an underdose of Boostrix, which led to accidental underdose.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Accidental underdose
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MA
- Alter
- 42,0
- Geschlecht
- F
- Eingang
- 15.07.2022
- Impfdatum
- 11.07.2022
- Beginn
- 11.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
administered 11Jul2022, expiration date 05Jul2022; This case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a 42-year-old female patient who received DTPa (Reduced antigen) (Boostrix) (batch number 229AN, expiry date 5th July 2022) for prophylaxis. On 11th July 2022, the patient received Boostrix. On 11th July 2022, unknown after receiving Boostrix, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown. Additional Information: GSK receipt date: 11-Jul-2022 Reporter's comment: The nurse reported that the patient was administered a dose of Boostrix on the day of reporting, which had an expiration date of 5th July 2022. At the time of reporting, dose had not been repeated. The vaccine administration facility was the same as primary reporter. The reporter consented to follow-up. Additional supportive information: The patient received an expired dose of Boostrix, which led to expired vaccine used.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- -
- Geschlecht
- F
- Eingang
- 15.07.2022
- Impfdatum
- 07.07.2022
- Beginn
- 07.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
expiration date of 05Jul2022; This case was reported by a pharmacist via call center representative and described the occurrence of expired vaccine used in a 92-year-old female patient who received DTPa (Reduced antigen) (Boostrix) (batch number 229AN, expiry date 5th July 2022) for prophylaxis. On 7th July 2022, the patient received Boostrix. On 7th July 2022, unknown after receiving Boostrix, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown. Additional Information: GSK Receipt Date: 08-JUL-2022 Reporter's comment: The pharmacist reported that the patient received dose of Boostrix which had expired on 5th July 2022. At the time of reporting, repeat dose had not been administered. The vaccine administration facility was the same as primary reporter. The reporter did not have patient initials available at time of call. The reporter did not consent to follow-up. Additional Supportive Information: The patient received a dose of Boostrix which was already expired, which led to expired vaccine used.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 64,0
- Geschlecht
- F
- Eingang
- 15.07.2022
- Impfdatum
- 07.07.2022
- Beginn
- 07.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
Patient received expired Boostrixdose; This case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a 64-year-old female patient who received DTPa (Reduced antigen) (Boostrix) (batch number 229AN, expiry date 5th July 2022) for prophylaxis. On 7th July 2022, the patient received Boostrix. On 7th July 2022, unknown after receiving Boostrix, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown. Additional Information: GSK receipt date: 7-Jul-2022 Reporter's comment: The nurse reported that the patient received an expired dose of Boostrix vaccine in left deltoid. The reporter consented to follow-up. Additional supportive information: The patient received an expired dose of Boostrix, which led to expired vaccine used.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 64,0
- Geschlecht
- F
- Eingang
- 07.07.2022
- Impfdatum
- 07.07.2022
- Beginn
- 07.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
No adverse event
Symptomtext
Vaccine expired 07/05/22. Administered 07/07/22. No adverse signs or symptoms.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- Ceclor
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 30,0
- Geschlecht
- F
- Eingang
- 27.05.2022
- Impfdatum
- 20.05.2022
- Beginn
- 20.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Inappropriate schedule of product administration
Symptomtext
received an unknown Tdap on 5/17/2021, Boostrix on 5/20/22; This case was reported by a other health professional via call center representative and described the occurrence of drug dose administration interval too short in a 30-year-old female patient who received DTPa (Reduced antigen) (Boostrix) (batch number 229AN, expiry date 5th July 2022) for prophylaxis. Previously administered products included tdap (on 17th May 2021 the patient received unknown Tdap). On 20th May 2022, the patient received Boostrix. On 20th May 2022, unknown after receiving Boostrix, the patient experienced drug dose administration interval too short. On an unknown date, the outcome of the drug dose administration interval too short was unknown. Additional Information: GSK Receipt Date: 23-MAY-2022 Reporter's Comments: The reporter was a medical assistant. The reporter stated that the patient received an unknown Tdap and now received Boostrix. The reporter inquired what to look for and how to proceed. The reporter consented to follow up. Additional Supportive Information: The patient received an unknown Tdap and now received Boostrix prior to recommended interval, which led to shortening of vaccination schedule
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Inappropriate schedule of product administration
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 11,0
- Geschlecht
- M
- Eingang
- 22.03.2022
- Impfdatum
- 30.11.2021
- Beginn
- 30.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
No adverse event
Product storage error
Symptomtext
Pediatric Pfizer Vaccine Lot Number FK5127, was improperly stored in an Immunizations Freezer that maintained a temperature between -15 Celsius and -24 Celsius. Per the Manufacture?s guidelines the vaccine must be stored in a Refrigerator maintaining temperature of 2-8 Degrees Celsius or an Ultra-Low Cold Freezer maintaining temperature of -90C or lower. The patient received the vaccine that was improperly stored. Treatment: Not required, patient did not report any adverse reactions to the Vaccine. Outcome: Patient?s guardian notified and offered to restart the Pediatric Pfizer Covid Vaccine series again stored at the proper temperature. Signs, Symptoms course, etc. None reported by the patient?s guardian
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 11,0
- Geschlecht
- F
- Eingang
- 21.03.2022
- Impfdatum
- 11.01.2022
- Beginn
- 11.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
Pediatric Pfizer Vaccine Lot Number FK5127, was improperly stored in an Immunizations Freezer that maintained a temperature between -15 Celsius and -24 Celsius. Per the Manufacture?s guidelines the vaccine must be stored in a Refrigerator maintaining temperature of 2-8 Degrees Celsius or an Ultra-Low Cold Freezer maintaining temperature of -90C or lower. The patient received the vaccine that was improperly stored. Treatment: Not required, patient did not report any adverse reactions to the Vaccine.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- SC
- Alter
- 7,0
- Geschlecht
- U
- Eingang
- 11.02.2022
- Impfdatum
- -
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product administered to patient of inappropriate age
Symptomtext
7yo patient received Boostrix; This case was reported by a nurse via call center representative and described the occurrence of inappropriate age at vaccine administration in a 7-year-old patient who received DTPa (Reduced antigen) (Boostrix) (batch number 229AN, expiry date 5th July 2022) for prophylaxis. Previously administered products included Infanrix (received their first 4 doses when they were younger). On an unknown date, the patient received Boostrix. On an unknown date, unknown after receiving Boostrix, the patient experienced inappropriate age at vaccine administration. On an unknown date, the outcome of the inappropriate age at vaccine administration was unknown. Additional details were provided as follows: The registered nurse reported that 7 year old patient received Boostrix a couple months prior to the reporting as their 5th dose which led to inappropriate age at vaccine administration. No patient details or date of administration was available for Infanrix doses. The reporter consented to follow up.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- AZ
- Alter
- 11,0
- Geschlecht
- M
- Eingang
- 28.10.2021
- Impfdatum
- 14.08.2021
- Beginn
- 14.08.2021
- Tage bis Beginn
- 0,0
- Dosis
- N/A
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Extra dose administered
Symptomtext
Pt received an extra dose of T-dap/ record not reviewed properly prior to ordering dose
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- unknown
- Vorgeschichte
- unknown
- Andere Medikamente
- unknown
- Allergien
- unknown
- Vorherige Impfungen
- -
- Staat
- MN
- Alter
- 78,0
- Geschlecht
- M
- Eingang
- 04.08.2021
- Impfdatum
- 03.08.2021
- Beginn
- 03.08.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Extra dose administered
No adverse event
Wrong product administered
Symptomtext
patient arrived to receive tdap. the correct vaccine was brought to the vaccination room. there were covid vaccines already set up. after talking with the patient, vaccinator grabbed a covid shot mistakenly and provided a third pfizer vaccine. patient had already completed the pfizer regimen. there were no apparent side effects at the time or when the patient returned the next day for an unrelated reason
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- unknown
- Vorgeschichte
- unknown
- Andere Medikamente
- unknown
- Allergien
- no known allergies on file
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- 6,0
- Geschlecht
- M
- Eingang
- 02.08.2021
- Impfdatum
- 02.08.2021
- Beginn
- 02.08.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Product administered to patient of inappropriate age
Symptomtext
Patient's guardian provided DOB for patient making the patient 8 years of age. Verified the name and DOB in the room with guardian, guardian stated this was correct. Per immunization record the patient needed Tdap vaccine for incomplete Dtap series because he was older than 7. After injections given and patient was checking out, guardian stated a different DOB, making patient 6 years of age and ineligible for Tdap that was already administered.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- None
- Vorherige Impfungen
- -